MYC and neoplasm: High TXNDC12 levels promote c-Myc interaction with USP5, inhibit proteasomal degradation of c-Myc, and activate the c-Myc signaling pathway, thereby facilitating tumor invasion, proliferation, and cisplatin resistance (53).